Patents by Inventor Judy Ruckman

Judy Ruckman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid ligands to integrins
    Publication number: 20070010473
    Abstract: Methods are described for the isolation of nucleic acid ligands to integrins using the SELEX process. SELEX is an acronym for Systematic Evolution of Ligands by EXponential enrichment. The nucleic acid ligands of the present invention are useful as therapeutic and diagnostic agents.
    Type: Application
    Filed: August 22, 2006
    Publication date: January 11, 2007
    Applicant: Gilead Sciences, Inc.
    Inventors: Judy Ruckman, Larry Gold, Andrew Stephens, Nebojsa Janjic
  • Nucleic acid ligands to integrins
    Patent number: 7094535
    Abstract: Methods are described for the isolation of nucleic acid ligands to integrins using the SELEX process. SELEX is an acronym for Systematic Evolution of Ligands by EXponential enrichment. The nucleic acid ligands of the present invention are useful as therapeutic and diagnostic agents.
    Type: Grant
    Filed: December 18, 2001
    Date of Patent: August 22, 2006
    Assignee: Gilead Sciences, Inc.
    Inventors: Judy Ruckman, Larry Gold, Andrew Stephens, Nebojsa Janjic
  • Nucleic acid ligands to integrins
    Publication number: 20020150536
    Abstract: Methods are described for the isolation of nucleic acid ligands to integrins using the SELEX process. SELEX is an acronym for Systematic Evolution of Ligands by EXponential enrichment. The nucleic acid ligands of the present invention are useful as therapeutic and diagnostic agents.
    Type: Application
    Filed: December 18, 2001
    Publication date: October 17, 2002
    Applicant: GILEAD SCIENCES, INC.
    Inventors: Judy Ruckman, Larry Gold, Andrew Stephens, Nebojsa Janjic
  • Nucleic acid ligands to integrins
    Patent number: 6331394
    Abstract: Methods are described for the isolation of nucleic acid ligands to integrins using the SELEX process. SELEX is an acronym for Systematic Evolution of Ligands by EXponential enrichment. The nucleic acid ligands of the present invention are useful as therapeutic and diagnostic agents.
    Type: Grant
    Filed: July 29, 1999
    Date of Patent: December 18, 2001
    Assignee: Gilead Sciences, Inc.
    Inventors: Judy Ruckman, Larry Gold, Andrew Stephens, Nebojsa Janjic